DPP IV is a transmembrane serine protease enzyme whose expression is up regulated in a variety of diseases therefore has been identified as potential diagnostic or prognostic marker for various ... tumors…
rapidly degraded in vivo by the serine protease dipeptidyl peptidase-4 (DPP-4); therefore, DPP-4 inhibitors have emerged as a new therapeutic option to treat type 2 diabetes ... thienopyrimidine derivatives was designed…
Dipeptidyl peptidase-4 (DPP-4) is a transmembrane serine aminopeptidase which cleaves X-proline dipeptides which degrades incretin hormones in turn stimulating insulin release with reduced GLP-1 secretion ... type 2…
Decapentaplegic (Dpp) is the homolog of vertebrate BMP-2 and BMP-4 and functionally interchangeable BMPs. The Bombyx mori (B. mori) and Bombyx mandarina (B. mandarina) Dpp genes share genetic ... homology with human…
available structural information is indispensable for the development of virtual screening protocol. Various DPP-IV inhibitors have been approved in recent years for the management of type-2-diabetes. Structure…
highly expressed in pancreatic β-cell and potentially play a role in the DPP-4 inhibitor treatment response in type 2 diabetes. The objective of this study was to investigate ... association of WFS1 genes with the DPP-4…
event reports (ADRs) associated with widely used anti-diabetic drugs of dipeptidyl peptidase 4 (DPP 4) inhibitors were generated and evaluated. Standardized pharmacovigilance tools were applied to detect the signal…
universal treatment guideline applicable to all patients. Hence to evaluate individual newer drugs like DPP-4 inhibitors for their efficacy, safety and long-term treatment outcome, this study was conducted ... about the…
Since SDF-1, like GLP-1, is a substrate of dipeptidyl peptidase-4 (DPP-4), we examined whether dual therapy with SDF-1 and a DPP-4 inhibitor would preserve ... alpha or vehicle for 5 days. These mice were concurrently…
DPP-4 inhibitors have been used to treat patients with type 2 diabetes mellitus. These agents not only provide glycemic control, but also have other favorable effects, including the prevention ... type 2 diabetes…
Dipeptidyl Peptidase IV or molecule CD26 (DPP IV/CD26) is a multifunctional protein, identified as a therapeutic target for type 2 diabetes, due to its ability to degrade incretins, insulin ... patients that represents…
incretin hormone GLP-1 targets this islet dysfunction. GLP-1 is inactivated by DPP-4 and, consequently, DPP-4 inhibition has evolved as an efficient treatment of hyperglycemia in Type ... diabetes since it increases the…
QSAR) study was performed on 5β-methylprolyl-2-cyanopyrrolidine derivatives as dipeptidyl peptidase IV (DPP IV) inhibitors using molecular design suite software (VLifeMDS). This study was performed with 30 compounds
Dipeptidyl peptidase III (DPP III), also known as enkephalinase B, belongs to family of M49 of zinc-dependent metallopeptidases and cleaves dipeptides sequentially from the N-terminus of numerous bioactive ... aspect to…
development of a novel TLC-bioautographic method on detection of dipeptidyl peptidase IV (DPP IV) inhibitors from plant extracts will be described. The focus of the example will ... reaction products via derivatization…
21st century as the prevalence of diabetes is increased apace. Dipeptidyl Peptidase IV (DPP IV) inhibitors are relatively new therapy for management of T2D. Inhibition of DPP ... attractive new approach to the…
trials (RCTs) before 2014 on the extent of impact of dipeptidyl peptidase-4 inhibitor (DPP-4 I) drugs on overall mortality in patients of type 2 diabetes mellitus. TheDPP
they have very short half life) by proteolytic enzymers, such as dipeptidyl peptidase 4 (DPP-4) into inactive metabolite, thereby limiting the use of GLP-1 as a drug. Thus ... because of multiple benefits of GLP-1…
designed computationally and screened through insilico docking studies against crystal structure of Dipeptidylpeptidase-IV (DPP-IV) as a projected target for Type 2 Diabetes Mellitus. Insilico docking (rigid and…
prepare novel derivative of metformin similar to the work of the enzyme inhibitors dpp-4 and so the need for new inhibitors may be a side effect with less addition ... statistical analysis showed a significant decrease…
been shadowed by signals of more or less severe toxic side-effects, but the DPP-4 Inhibitors (DPP-4) have been gaining the reputation, based on interpretations of short
ipeptidyl peptidase IV (DPP-IV) is an enzyme of considerable biomedical interest. It plays an important role in glucose homeostasis through proteolytic inactivation of incretin hormones, primarily glucagon like peptide…
performed on a series of 4-flouro-2- cyanopyrrolidine derivatives possessing Dipeptidyl Peptidase IV (DPP IV) inhibitory activity for establishing quantitative relationship between biological activity and their…
most recent therapeutic choices for the management of T2DM are dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon-like peptide 1 (GLP-1) receptor agonists and sodium–glucose cotransporter 2 (SGLT
dipeptidyl peptidase-4 DPP-IV is the major receptor of the new oral treatments for diabetes type II. This work determined the structural similarities of the protein
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.